However, no significant difference was observed in VASH2 expression levels in WBCs between cancer patients and controls (1.15 ± 0.37 folds, p = 0.3030 by Mann–Whitney U tests; Kolmogorov–Smirnov test, p < 0.0100). Here, VASH2 is linked to cancer.